1. Cost-Effectiveness of Sertindole among Atypical Antipsychotics in the Treatment of Schizophrenia in South Korea 
Bo-Ra-Mi Kim, MPH, Tae-Jin Lee, PhD, Hye-Jae Lee, MPH, Bo-Hyun Park, PhD, Bong-Min Yang, PhD 
Value in Health Regional Issues 
Volume 1, Issue 1, Pages (May 2012)
DOI: /j.vhri
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2. Fig. 1
Markov model for cost-effectiveness analysis. Comp +, compliant; Comp −, noncompliant; EPS, extrapyramidal symptoms; M, Markov; Rel +, relapse; Rel −, nonrelapse.
Value in Health Regional Issues 2012 1, 59-65DOI: ( /j.vhri )
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

3. Fig. 2 Flow of systematic review. RCT, randomized controlled trial.
Value in Health Regional Issues 2012 1, 59-65DOI: ( /j.vhri )
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

4. Fig. 3 Cost-effectiveness (CE) scatter plot.
Value in Health Regional Issues 2012 1, 59-65DOI: ( /j.vhri )
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions